We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Anti-TNF-alpha therapies: the next generation.
- Authors
Palladino, Michael A; Bahjat, Frances Rena; Theodorakis, Emmanuel A; Moldawer, Lyle L
- Abstract
The functioning of the immune system is finely balanced by the activities of pro-inflammatory and anti-inflammatory mediators or cytokines. Unregulated activities of these mediators can lead to the development of serious inflammatory diseases. In particular, enhanced tumour-necrosis factor-alpha (TNF-alpha) synthesis is associated with the development of rheumatoid arthritis, psoriatic arthritis and inflammatory bowel disease. Inhibiting TNF-alpha activities in these diseases has been remarkably successful. However, the current injectable protein therapies have associated risks and limitations. An oral, small molecule that regulates TNF-alpha biology could either replace the injectables or provide better disease control when used alone or in conjunction with existing therapies. In this review, we discuss briefly the present understanding of TNF-alpha-mediated biology and the current injectable therapies in clinical use, and focus on some of the new therapeutic approaches with oral, small-molecule inhibitors.
- Publication
Nature reviews. Drug discovery, 2003, Vol 2, Issue 9, p736
- ISSN
1474-1776
- Publication type
Journal Article
- DOI
10.1038/nrd1175